Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023574066> ?p ?o ?g. }
- W2023574066 endingPage "41" @default.
- W2023574066 startingPage "35" @default.
- W2023574066 abstract "No AccessJournal of UrologyAdult Urology1 Jan 2009Long-Term Outcomes After Nephron Sparing Surgery for Renal Cell Carcinoma Larger Than 4 cm Matthieu Peycelon, Vincent Hupertan, Eva Comperat, Raphaële Renard-Penna, Christophe Vaessen, Pierre Conort, Marc-Olivier Bitker, Emmanuel Chartier-Kastler, François Richard, and Morgan Rouprêt Matthieu PeycelonMatthieu Peycelon Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author , Vincent HupertanVincent Hupertan Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author , Eva ComperatEva Comperat Department of Pathology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author , Raphaële Renard-PennaRaphaële Renard-Penna Department of Radiology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author , Christophe VaessenChristophe Vaessen Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author , Pierre ConortPierre Conort Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author , Marc-Olivier BitkerMarc-Olivier Bitker Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author , Emmanuel Chartier-KastlerEmmanuel Chartier-Kastler Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author , François RichardFrançois Richard Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author , and Morgan RouprêtMorgan Rouprêt Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2008.09.025AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We determined the cancer control provided by nephron sparing surgery for renal cell carcinoma greater than 4 cm. Materials and Methods: We performed a retrospective review of data on patients treated between 1980 and 2005. The case characteristics analyzed were patient age, surgical procedure, intraoperative parameters, complications, tumor size, Fuhrman grade, TNM stage, pathological data and outcome. Kaplan-Meier survival curves were generated. Results: Median age of the 61 patients was 64 years (range 40 to 83). Mean ± SD intraoperative blood loss was 622 ml ± 691 (range 50 to 4,800) and mean operative time was 155.7 ± 82 minutes (range 52 to 360). Mean creatinine preoperatively and immediately postoperatively was 1.16 and 1.25 mg/dl, respectively. Mean renal cell carcinoma size was 56.3 ± 18 mm (range 41 to 100). Margin status was positive in 11 cases (18%). Median followup was 70.7 months. The 5 and 10-year cancer specific survival rate was 81% and 78%, respectively. The tumor-free survival rate was 92% at 5 years and 88% at 10 years. On univariate analysis tumor size more than 7 cm (p = 0.002), pathological stage (p = 0.001) and Fuhrman grade (p = 0.004) were associated with survival. On multivariate analysis only pathological stage and Fuhrman grade were significant (p <0.0001 and 0.007, respectively). Conclusions: Our results support the fact that nephron sparing surgery is a useful and acceptable approach to renal cell carcinoma greater than 4 cm. When technically possible, nephron sparing surgery provides acceptable long-term cancer specific survival rates. However, oncological safety is less evident in cases of renal cell carcinoma greater than 7 cm. To date in such cases nephron sparing surgery should only be considered for absolute indications. References 1 : Cancer statistics, 2006. CA Cancer J Clin2006; 56: 106. Google Scholar 2 : Renal cell carcinoma guideline. Eur Urol2007; 51: 1502. Google Scholar 3 : Comparison of laparoscopic radical and partial nephrectomy: effects on long-term serum creatinine. Urology2007; 69: 1035. Google Scholar 4 : Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol2000; 163: 730. Link, Google Scholar 5 : Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients. 1989. J Urol2002; 167: 878. Link, Google Scholar 6 : Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. J Urol2002; 168: 454. Link, Google Scholar 7 : Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival. J Urol2006; 175: 2022. Link, Google Scholar 8 : Does the size of the surgical margin in partial nephrectomy for renal cell cancer really matter?. J Urol2002; 167: 61. Link, Google Scholar 9 : Prospective study of safety margins in partial nephrectomy: intraoperative assessment and contribution of frozen section analysis. Urology2006; 67: 923. Google Scholar 10 : Tumor size and nephron-sparing surgery: does it still matter?. Eur Urol2008; 53: 691. Google Scholar 11 : Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol2008; 179: 1719. Link, Google Scholar 12 : Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7cm. Eur Urol2008; 53: 803. Google Scholar 13 : Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm. Eur Urol2006; 49: 1058. Google Scholar 14 : Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cm. BJU Int2006; 97: 939. Google Scholar 15 : Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or larger. Urology2006; 67: 260. Google Scholar 16 : Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol2004; 171: 1066. Link, Google Scholar 17 : Nephron sparing surgery for renal cell carcinoma and von Hippel-Lindau's disease: a single center experience. J Urol2003; 170: 1752. Link, Google Scholar 18 : Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology2002; 59: 816. Google Scholar 19 : Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol2004; 171: 2181. Link, Google Scholar 20 : Laparoscopic partial nephrectomy for hilar tumors. J Urol2005; 174: 850. Link, Google Scholar 21 : Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol1999; 162: 1930. Link, Google Scholar © 2009 by American Urological AssociationFiguresReferencesRelatedDetailsCited byHew M, Baseskioglu B, Barwari K, Axwijk P, Can C, Horenblas S, Bex A, de la Rosette J and Laguna Pes M (2011) Critical Appraisal of the PADUA Classification and Assessment of the R.E.N.A.L. Nephrometry Score in Patients Undergoing Partial NephrectomyJournal of Urology, VOL. 186, NO. 1, (42-46), Online publication date: 1-Jul-2011.Gupta G, Peterson J, Thakore K, Pinto P, Linehan W and Bratslavsky G (2010) Oncological Outcomes of Partial Nephrectomy for Multifocal Renal Cell Carcinoma Greater Than 4 cmJournal of Urology, VOL. 184, NO. 1, (59-63), Online publication date: 1-Jul-2010. Volume 181Issue 1January 2009Page: 35-41 Advertisement Copyright & Permissions© 2009 by American Urological AssociationKeywordsrenal cellcarcinomakidneymortalityneoplasm recurrenceMetrics Author Information Matthieu Peycelon Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author Vincent Hupertan Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author Eva Comperat Department of Pathology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author Raphaële Renard-Penna Department of Radiology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author Christophe Vaessen Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author Pierre Conort Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author Marc-Olivier Bitker Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author Emmanuel Chartier-Kastler Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author François Richard Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author Morgan Rouprêt Department of Urology, Groupement Hospitalier Universitaire Est (Pitié-Tenon), Assistance-Publique Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France More articles by this author Expand All Advertisement PDF downloadLoading ..." @default.
- W2023574066 created "2016-06-24" @default.
- W2023574066 creator A5025197801 @default.
- W2023574066 creator A5035860973 @default.
- W2023574066 creator A5040219451 @default.
- W2023574066 creator A5041352205 @default.
- W2023574066 creator A5051206259 @default.
- W2023574066 creator A5059810898 @default.
- W2023574066 creator A5063195568 @default.
- W2023574066 creator A5063399385 @default.
- W2023574066 creator A5064914239 @default.
- W2023574066 creator A5074110497 @default.
- W2023574066 date "2009-01-01" @default.
- W2023574066 modified "2023-10-18" @default.
- W2023574066 title "Long-Term Outcomes After Nephron Sparing Surgery for Renal Cell Carcinoma Larger Than 4 cm" @default.
- W2023574066 cites W1963592300 @default.
- W2023574066 cites W1972835830 @default.
- W2023574066 cites W1973572446 @default.
- W2023574066 cites W1977446166 @default.
- W2023574066 cites W1978654287 @default.
- W2023574066 cites W1981972946 @default.
- W2023574066 cites W1993844148 @default.
- W2023574066 cites W2013839667 @default.
- W2023574066 cites W2020069877 @default.
- W2023574066 cites W2023932250 @default.
- W2023574066 cites W2026095991 @default.
- W2023574066 cites W2046700945 @default.
- W2023574066 cites W2074450945 @default.
- W2023574066 cites W2095555590 @default.
- W2023574066 cites W2098806433 @default.
- W2023574066 cites W2122129168 @default.
- W2023574066 cites W2148491024 @default.
- W2023574066 cites W2151546172 @default.
- W2023574066 cites W2160930438 @default.
- W2023574066 cites W3049036847 @default.
- W2023574066 cites W4245766263 @default.
- W2023574066 cites W4361744597 @default.
- W2023574066 doi "https://doi.org/10.1016/j.juro.2008.09.025" @default.
- W2023574066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19012929" @default.
- W2023574066 hasPublicationYear "2009" @default.
- W2023574066 type Work @default.
- W2023574066 sameAs 2023574066 @default.
- W2023574066 citedByCount "126" @default.
- W2023574066 countsByYear W20235740662012 @default.
- W2023574066 countsByYear W20235740662013 @default.
- W2023574066 countsByYear W20235740662014 @default.
- W2023574066 countsByYear W20235740662015 @default.
- W2023574066 countsByYear W20235740662016 @default.
- W2023574066 countsByYear W20235740662017 @default.
- W2023574066 countsByYear W20235740662018 @default.
- W2023574066 countsByYear W20235740662019 @default.
- W2023574066 countsByYear W20235740662020 @default.
- W2023574066 countsByYear W20235740662021 @default.
- W2023574066 crossrefType "journal-article" @default.
- W2023574066 hasAuthorship W2023574066A5025197801 @default.
- W2023574066 hasAuthorship W2023574066A5035860973 @default.
- W2023574066 hasAuthorship W2023574066A5040219451 @default.
- W2023574066 hasAuthorship W2023574066A5041352205 @default.
- W2023574066 hasAuthorship W2023574066A5051206259 @default.
- W2023574066 hasAuthorship W2023574066A5059810898 @default.
- W2023574066 hasAuthorship W2023574066A5063195568 @default.
- W2023574066 hasAuthorship W2023574066A5063399385 @default.
- W2023574066 hasAuthorship W2023574066A5064914239 @default.
- W2023574066 hasAuthorship W2023574066A5074110497 @default.
- W2023574066 hasConcept C121332964 @default.
- W2023574066 hasConcept C126322002 @default.
- W2023574066 hasConcept C126894567 @default.
- W2023574066 hasConcept C141071460 @default.
- W2023574066 hasConcept C143998085 @default.
- W2023574066 hasConcept C2777472916 @default.
- W2023574066 hasConcept C2777546739 @default.
- W2023574066 hasConcept C2780091579 @default.
- W2023574066 hasConcept C2781231759 @default.
- W2023574066 hasConcept C61797465 @default.
- W2023574066 hasConcept C62520636 @default.
- W2023574066 hasConcept C71924100 @default.
- W2023574066 hasConceptScore W2023574066C121332964 @default.
- W2023574066 hasConceptScore W2023574066C126322002 @default.
- W2023574066 hasConceptScore W2023574066C126894567 @default.
- W2023574066 hasConceptScore W2023574066C141071460 @default.
- W2023574066 hasConceptScore W2023574066C143998085 @default.
- W2023574066 hasConceptScore W2023574066C2777472916 @default.
- W2023574066 hasConceptScore W2023574066C2777546739 @default.
- W2023574066 hasConceptScore W2023574066C2780091579 @default.
- W2023574066 hasConceptScore W2023574066C2781231759 @default.
- W2023574066 hasConceptScore W2023574066C61797465 @default.
- W2023574066 hasConceptScore W2023574066C62520636 @default.
- W2023574066 hasConceptScore W2023574066C71924100 @default.
- W2023574066 hasIssue "1" @default.
- W2023574066 hasLocation W20235740661 @default.
- W2023574066 hasLocation W20235740662 @default.
- W2023574066 hasOpenAccess W2023574066 @default.
- W2023574066 hasPrimaryLocation W20235740661 @default.
- W2023574066 hasRelatedWork W1486019900 @default.
- W2023574066 hasRelatedWork W1568223466 @default.
- W2023574066 hasRelatedWork W2017205529 @default.
- W2023574066 hasRelatedWork W2077119618 @default.
- W2023574066 hasRelatedWork W2152046643 @default.